4-异丙基苯基乙酸乙酯 | 14062-21-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: 4-异丙基苯基乙酸乙酯
• 中文别名: 乙基4-异丙基苯基乙酸酯
• 英文名称: ethyl p-isopropylphenyl acetate
• 英文别名: (4-isopropylphenyl)acetic acid ethyl ester；p-Cumylessigsaeureaethylester；4-Isopropyl-phenyl-essigsaeure-ethylester；(4-Isopropyl-phenyl)-essigsaeure-aethylester；ethyl (4-isopropylphenoxy)acetate；ethyl 4-isopropylphenylacetate；ethyl 2-(4-propan-2-ylphenyl)acetate
• CAS: 14062-21-6
• 化学式: C₁₃H₁₈O₂
• 分子量: 206.285
• InChiKey: LFMYKNVKLMQSJV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2916399090

反应信息

• 作为反应物：
  描述：

  4-异丙基苯基乙酸乙酯 在 lithium aluminium tetrahydride 作用下， 以 乙醚 为溶剂， 生成 4-异丙基苯乙醇
  参考文献：
  名称：

  Evidence for hyperconjugative stabilization of olefins from tautomeric equilibria

  摘要：

  DOI：

  10.1021/jo01286a043
• 作为产物：
  描述：

  4-异丙基苄氯 在 硫酸 作用下， 以 乙醇 为溶剂， 生成 4-异丙基苯基乙酸乙酯
  参考文献：
  名称：

  van Zanten,B.; Nauta,W., Recueil des Travaux Chimiques des Pays-Bas, 1960, vol. 79, p. 1211 - 1222

  摘要：

  DOI：

文献信息

• [EN] PHENYL SUBSTITUTED PIPERIDINE COMPOUNDS FOR USE AS PPAR ACTIVATORS<br/>[FR] COMPOSES DE PIPERIDINE PHENYLE A SUBSTITUTION PHENYLE S'UTILISANT COMME ACTIVATEURS DE PPAR
  申请人：PFIZER PROD INC

  公开号：WO2004048334A1

  公开（公告）日：2004-06-10

  PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.

  PPARα激动剂，含有这类化合物的药物组合物以及利用这类化合物提高特定血浆脂质水平，包括高密度脂蛋白胆固醇，并降低其他特定血浆脂质水平，如低密度脂蛋白胆固醇和甘油三酯，并据此治疗由高密度脂蛋白胆固醇水平低和/或低密度脂蛋白胆固醇和甘油三酯水平高加重的疾病，如动脉粥样硬化和心血管疾病，在哺乳动物，包括人类中的应用。
• An efficient method for the preparation of mono α-aryl derivatives of diethyl malonate and ethyl cyanoacetate using ethyl-1-imidazole carbamate (EImC)
  作者：Manoranjan Behera、R. Venkat Ragavan、M. Sambaiah、Balaiah Erugu、J. Rama Krishna Reddy、K. Mukkanti、Satyanarayana Yennam

  DOI：10.1016/j.tetlet.2011.12.067

  日期：2012.2

  An efficient method for the synthesis of mono α-aryl derivatives of diethyl malonate and ethyl cyanoacetate using ethyl-1-imidazole carbamate (EImC) has been described. Using this method many sterically hindered and highly substituted mono α-aryl derivatives of diethyl malonate and ethyl cyanoacetate were synthesized in high yield.

  已经描述了使用-1-咪唑氨基甲酸乙酯（EImC）合成丙二酸二乙酯和氰基乙酸乙酯的单α-芳基衍生物的有效方法。用这种方法可以高产率地合成许多位阻和高度取代的丙二酸二乙酯和氰基乙酸乙酯的单α-芳基衍生物。
• A New Synthesis of Arylacetic Esters Starting from Aromatic Aldehyde by the Use of Methyl (Methylthio)methyl Sulfoxide
  作者：Katsuyuki Ogura、Yoko Ito、Gen-ichi Tsughihashi

  DOI：10.1246/bcsj.52.2013

  日期：1979.7

  Methyl (methylthio) methyl sulfoxide was found to react with benzaldehyde in the presence of benzyl tri-methylammonium hydroxide (Triton B), sodium hydroxide, or potassium hydroxide, affording 1-(methylsulfinyl)1-(methylthio)-2-phenylethylene. Treatment of this product with hydrogen chloride in an alcohol gave the corresponding alkyl phenylacetate in high yield. The whole reaction sequence provides

  发现甲基（甲硫基）甲基亚砜在苄基三甲基氢氧化铵（Triton B）、氢氧化钠或氢氧化钾的存在下与苯甲醛反应，得到 1-（甲基亚磺酰基）1-（甲硫基）-2-苯基乙烯。在醇中用氯化氢处理该产物以高产率得到相应的苯基乙酸烷基酯。整个反应序列为以苯甲醛为原料合成苯乙酸酯提供了一种新方法。以类似的方式，(烷氧基-、卤素-或烷基-取代的苯基)乙酸酯可以由相应的芳族醛合成。本方法显示也适用于(2-噻吩基)乙酸酯的生产。
• Modulators of cystic fibrosis transmembrane conductance regulator
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US10738030B2

  公开（公告）日：2020-08-11

  The present disclosure features a compound of formula I: or a pharmaceutically acceptable salt thereof, where R1, R2, W, X, Z, n, p, and Rings A and B are defined herein, for the treatment of CFTR mediated diseases, such as cystic fibrosis. The present disclosure also features pharmaceutical compositions, method of treating, and kits thereof.

  本发明公开了一种式 I 的化合物：或其药学上可接受的盐，其中 R1、R2、W、X、Z、n、p 和环 A 和环 B 在本文中定义，用于治疗 CFTR 介导的疾病，如囊性纤维化。本公开还包括药物组合物、治疗方法及其试剂盒。
• Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials
  作者：Lawrence B. Snyder、Zhaoxing Meng、Robert Mate、Stanley V. D’Andrea、Anne Marinier、Claude A. Quesnelle、Patrice Gill、Kenneth L. DenBleyker、Joan C. Fung-Tomc、MaryBeth Frosco、Alain Martel、John F. Barrett、Joanne J. Bronson

  DOI：10.1016/j.bmcl.2004.06.076

  日期：2004.9

  A series of potential antimicrobial derivatives possessing bioisosteric replacements for the central oxazolidinone ring found in oxazolidinone antibacterials have been prepared. The design concept involved replacement of the requisite SP3-hybridized stereogenic center found at the 5-position of the oxazolidinone with a nitrogen atom. The synthesis and antibacterial activity of three such ring systems, the benzisoxazolinones, pyrroles, and isoxazolinones is described. (C) 2004 Elsevier Ltd. All rights reserved.